DeutschNewstral
Article
nwaonline.com on 2023-10-10 09:16
Bristol-Myers buys Mirati to expand product lines
Related news
Bristol-Myers buys Mirati to expand product linesArkansas Online- TBristol Myers to buy cancer specialists Mirati Therapeutics for $5.8 billionthestreet.com
Bristol-Myers Squibb changes leadershipPhilly.com
New CEO takes over Bristol-Myers SquibbThe Salt Lake Tribune- HBristol-Myers Squibb Buying Celgene in $74B Dealhamodia.com
Bristol-Myers Squibb buying Celgene in $74B dealneworleanscitybusiness.com
Bristol-Myers drug fails lung cancer study, shares plungedothaneagle.com- IBristol-Myers is spending $5.8 billion to buy Mirati Therapeuticsinvezz.com
Supreme Court Solidifies Specific Jurisdiction Analysis To Dismiss Product Claims Filed Against Non-Resident Defendant, Bristol-Myers Squibb Co.jdsupra.com
Bristol-Myers coming to CambridgeBoston Herald
Bristol Myers Squibb buys San Diego cancer therapy company for $4.8BMerced Sun-Star- Bristol-Myers to buy drugmaker Celgene in deal set at $74Bnwaonline.com
Bristol-Myers Squibb buying Celgene in $74B deal - Thu, 03 Jan 2019 PSTThe Spokesman-Review- SolarCity, Bristol-Myers climb; Adobe, HP stumbleThe Salt Lake Tribune
- Bristol-Myers, Tiffany are big market moversThe Salt Lake Tribune
Buy Bristol-Myers Squibb For 25% Gains?Forbes- Newmont, Papa John's dip; Bristol-Myers risesThe Salt Lake Tribune